Financial statements Opharm
Cash flow statement of Opharm
Share capital:
Share capital:
1 250 000 PLN
Company deleted from KRS: 2024-11-28
Cash inflows of OPHARM
|
Year
|
2021
|
2022
|
2023
|
|---|---|---|---|
| Net cash from operating expenses | 20 878 966,13 | 8 639 302,10 | 441 986,96 |
| Net cash flow from investing activities | -4 823 974,81 | -16 841 220,78 | -1 612 235,03 |
| Net cash flow from financial activities | -7 029 564,95 | 748 096,51 | -1 257 120,55 |
| Total net cash flow | 9 025 426,37 | -7 453 822,17 | -2 427 368,62 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.